Join the American Lung Association's NYS Children's Asthma Initiative on May 16th, 2024 from 8am-9am. Dr. Krishnan will review Single Maintenance and Reliever Therapy for asthma management. Dr. Sankaran Krishnan is a pediatric pulmonologist, associate Professor of Pediatrics and Clinical Public Health, research director at Boston Children’s Health Physicians, New York Medical College, Children’s Environmental […]
Join the American Lung Association's NYS Children's Asthma Initiative on May 30th, 2024 from 12:30pm- 1:30pm. Dr. David Hill will review the scientific evidence regarding climate change. His presentation will discuss the effects of climate change on temperature, pollutants, and allergens and the importance of these factors for patients with asthma, as well as reviewing responses […]
Please join us on Wednesday, June 12 from 2:00 to 3:00 pm ET for the next Healthy People 2030 Webinar Series event focused on the impact of indoor and outdoor air quality on health. This webinar, Air Quality Matters: Improving Health and Lung Function with Healthy People 2030 Objectives, will highlight progress to date on […]
Free Webinar | July 25, 2024 | 4 PM ET SMART therapy is for patients with moderate to severe asthma who need a combination treatment. This combined treatment consists of an inhaled corticosteroid and an inhaled long-acting beta-2 agonist (LABA). Under asthma guidelines, SMART therapy is recommended for people with moderate to severe asthma, including […]
Wednesday, July 10th: Jodi Gilman, PhD | Medical and Non-Medical Cannabis Use: Potential Implications on Cognition and Clinical Outcomes Register here. Objectives: Differentiate between various research methods used to study the effects of cannabis on various populations, including adolescents and adults with comorbid health conditions Analyze cannabis’ neurological and cognitive impacts, focusing on differences in […]
Thursday, July 11th: Ken Finn, MD | Cannabis, Opioids, and Public Health Implications Register here. Objectives: Understand the close relationship between opioids and cannabinoids systems Understand what conditions cannabinoids may possibly work for and how expanded cannabis programs impacted the opioid epidemic Continuing Education Credits for Live Webinars Each webinar is approved by the NASW-Michigan Continuing […]
Friday, July 12th: Karen Osilla, PhD | Advances in Motivational Interviewing: Practical Strategies for Empowering People to Change Register here. Objectives: Describe latest advances in Motivational Interviewing (MI) (4th Edition) Share three tips for successfully delivering MI drawing from the latest MI research on “what works” Describe ways to empower individuals to change Continuing Education Credits […]
Monday, July 15th: Roneet Lev | It’s Just Pot. What’s the Problem? Register here. Objectives: Recognize cannabis related medical conditions Learn to check for drug interactions with cannabis products Encourage including cannabis in ICD-10 diagnosis Continuing Education Credits for Live Webinars Each webinar is approved by the NASW-Michigan Continuing Education Collaborative, Provider Number MICEC-0017. Each webinar […]
Free Webinar July 16, 2024 | 12 PM ET Asthma and allergy treatment has seen remarkable innovation in the last 25 years, but this progress is still not reaching everyone. More than 25 million Americans have asthma and 50+ million have allergies. These conditions disproportionately impact Black, Hispanic/Latino and Native American communities. Social, economic, and […]
Friday, July 19th: Leslie Lundahl, PhD | Adolescent Cannabis Use Register here. Objectives: Describe current trends in adolescent cannabis use List new cannabis formulations and routes of administration Define effects and potential risks of cannabis use Discuss screening and intervention for adolescent cannabis users Continuing Education Credits for Live Webinars Each webinar is approved by the […]
Free Webinar | July 25, 2024 | 4 PM ET SMART therapy is for patients with moderate to severe asthma who need a combination treatment. This combined treatment consists of an inhaled corticosteroid and an inhaled long-acting beta-2 agonist (LABA). Under asthma guidelines, SMART therapy is recommended for people with moderate to severe asthma, including […]
Attendees will learn about— Serious and growing risks from wildfire smoke to people with asthma and other respiratory diseases. How to use data, equipment, and community networks to prepare to deliver IEDOH solutions for people with asthma and others at risk from wildfire smoke. Communities financing and delivering indoor air cleaners, replacement filters, environmental education, […]
INHALE prepares regular PO and Clinical level newsletters that contain:
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.
